Celecoxib and ion channels: a story of unexpected discoveries

Eur J Pharmacol. 2014 May 5:730:61-71. doi: 10.1016/j.ejphar.2014.02.032. Epub 2014 Mar 11.

Abstract

Celecoxib (Celebrex), a highly popular selective inhibitor of cyclooxygenase-2, can modulate ion channels and alter functioning of neurons and myocytes at clinically relevant concentrations independently of cyclooxygenase inhibition. In experimental systems varying from Drosophila to primary mammalian and human cell lines, celecoxib inhibits many voltage-activated Na(+), Ca(2+), and K(+) channels, including NaV1.5, L- and T-type Ca(2+) channels, KV1.5, KV2.1, KV4.3, KV7.1, KV11.1 (hERG), while stimulating other K(+) channels-KV7.2-5 and, possibly, KV11.1 (hERG) channels under certain conditions. In this review, we summarize the information currently available on the effects of celecoxib on ion channels, examine mechanistic aspects of drug action and the concomitant changes at the cellular and organ levels, and discuss these findings in the therapeutic context.

Keywords: COX-2 inhibitor; Calcium channel; Celecoxib; Potassium channel; Sodium channel.

Publication types

  • Review

MeSH terms

  • Animals
  • Celecoxib
  • Cyclooxygenase 2 Inhibitors / pharmacology*
  • Humans
  • Ion Channels / antagonists & inhibitors
  • Ion Channels / metabolism*
  • Pyrazoles / pharmacology*
  • Sulfonamides / pharmacology*

Substances

  • Cyclooxygenase 2 Inhibitors
  • Ion Channels
  • Pyrazoles
  • Sulfonamides
  • Celecoxib